Irinotecan is an active agent in untreated patients with metastatic colorectal cancer.
Year: 1996
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Authors: J A Conti, N E Kemeny, L B Saltz, Y Huang, W P Tong, T C Chou, M Sun, S Pulliam, C Gonzalez
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: G1585853568
OpenAlex ID: W1952371628